The liver has a profound impact on bone health and bone tissue also regulates liver function, and these findings imply that it is reasonable to utilize the AST/ALT ratio to aggressively screen and monitor patients with T2DM for osteopenia or osteoporosis. This evidence concerns the gene GPT and Osteopenia.